RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company`s President and Chief Executive Officer, Tod Woolf, Ph.D., will present a corporate overview at the Rodman & Renshaw Global Investment Conference on Friday, September 11, 2009 at 11:15am ET, at the New York Palace Hotel in New York City.
Dr. Woolf will also be participating in a panel discussion on RNAi Therapeutics, taking place on Thursday, September 10, 2009 at 8:25am ET.
A live webcast of the presentation will be available on the "Investors" section of the Company's website, www.rxipharma.com. A replay of the presentation will be available for 30 days.
No comments:
Post a Comment